The OCTARAY™ Mapping Catheter with TRUEref™ Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac ...
Please provide your email address to receive an email when new articles are posted on . Biosense Webster announced the launch of an FDA-cleared catheter with novel technology for mapping cardiac ...
The OCTARAY Mapping Catheter with TRUEref Technology is now available in the U.S. and EMEA and has been both CE marked and 510 (k) cleared by the U.S. Food and Drug Administration (FDA). For more ...
IRVINE, Calif., Sept. 6, 2022 /PRNewswire/ -- Biosense Webster, Inc., part of Johnson & Johnson MedTech ‡, today announced the release of the OCTARAY™ Mapping Catheter with TRUEref™ Technology powered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results